Cargando…

Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic

Background and Objectives: The COVID-19 pandemic caused by the Coronavirus SARS-CoV-2 is a complex challenge for the existing scientific and medical landscape. It is an ongoing public health crisis, with over 245,373,039 confirmed cases globally, including 4,979,421 deaths as of 29 October 2021. Exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonikman, Daniel, Kustovs, Dmitrijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608676/ https://www.ncbi.nlm.nih.gov/pubmed/37893528 http://dx.doi.org/10.3390/medicina59101810

Ejemplares similares

Cognition and Mental Health in Pediatric Patients Following COVID-19
por: Avittan, Hadar, et al.
Publicado: (2023)

Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy
por: Kustovs, Dmitrijs, et al.
Publicado: (2023)

Selenium Status and Oxidative Stress in SARS-CoV-2 Patients
por: Šķesters, Andrejs, et al.
Publicado: (2023)

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
por: Salmen, Teodor, et al.
Publicado: (2022)

Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
por: Sitovs, Andrejs, et al.
Publicado: (2020)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis
por: Mirabelli, Maria, et al.
Publicado: (2020)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Effects of antidiabetic drugs on epicardial fat
por: Xourgia, Eleni, et al.
Publicado: (2018)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Effects of Antidiabetic Drugs on Gut Microbiota Composition
por: Montandon, Sophie A., et al.
Publicado: (2017)

Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients
por: Rea, Federico, et al.
Publicado: (2023)

Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
por: Liu, Geng, et al.
Publicado: (2023)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019)

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
por: Tacelli, Matteo, et al.
Publicado: (2018)

Reduction in the Number of Procedures and Hospitalizations and Increase in Cancer Mortality During the COVID-19 Pandemic in Brazil
por: Fonseca, Gabriela A., et al.
Publicado: (2021)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021)

Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic
por: Schlosser, Allison, et al.
Publicado: (2020)

Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice
por: Stenman, Lotta K., et al.
Publicado: (2015)

Efficacy and Cardiovascular Safety of Antidiabetic Medications
por: Pappachan, Joseph M.
Publicado: (2021)

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
por: Casas-Rojo, José-Manuel, et al.
Publicado: (2023)

Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
por: Katsiki, Niki, et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs
por: Stanciu, Silviu, et al.
Publicado: (2023)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
por: Olatunde, Ahmed, et al.
Publicado: (2021)

Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach
por: Batisai, Eustina
Publicado: (2021)

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017)

The Antidiabetic Functions of the Pancreas and Successful Isolation of the Antidiabetic Hormone Insulin
Publicado: (1924)

Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States
por: Auty, Samantha G., et al.
Publicado: (2022)

Antidiabetic Effects of Tea
por: Fu, Qiu-Yue, et al.
Publicado: (2017)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

Mortality in Germany during the COVID-19 Pandemic
por: Pichler, Alois, et al.
Publicado: (2023)

Mobility and Mortality During the COVID-19 Pandemic
por: Zipursky, Jonathan S., et al.
Publicado: (2020)

Mortality surveillance during the COVID-19 pandemic
por: Setel, Philip, et al.
Publicado: (2020)

Underestimation of COVID-19 mortality during the pandemic
por: Kung, Stacey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dtm0hhk5cr3184bjcp3rnkt3on